This company listing is no longer active
Elliptic Laboratories Performance dei guadagni passati
Il passato criteri di controllo 0/6
Elliptic Laboratories's earnings have been declining at an average annual rate of -2.7%, while the Software industry saw earnings growing at 17.8% annually. Revenues have been growing at an average rate of 30.4% per year.
Informazioni chiave
-2.7%
Tasso di crescita degli utili
4.6%
Tasso di crescita dell'EPS
Software Crescita del settore | 15.7% |
Tasso di crescita dei ricavi | 30.4% |
Rendimento del capitale proprio | -10.7% |
Margine netto | -66.4% |
Prossimo aggiornamento sui guadagni | 13 Jul 2023 |
Aggiornamenti sulle prestazioni recenti
Recent updates
Ripartizione dei ricavi e delle spese
Come Elliptic Laboratories guadagna e spende denaro. In base agli ultimi utili dichiarati, su base LTM.
Storia dei guadagni e delle entrate
Data | Ricavi | Guadagni | Spese G+A | Spese di R&S |
---|---|---|---|---|
31 Mar 23 | 51 | -34 | 1 | 0 |
31 Dec 22 | 52 | -33 | 1 | 0 |
30 Sep 22 | 77 | -10 | 1 | 0 |
30 Jun 22 | 63 | -18 | 1 | 0 |
31 Mar 22 | 58 | -17 | 1 | 0 |
31 Dec 21 | 55 | -11 | 1 | 0 |
30 Sep 21 | 44 | -5 | 1 | 0 |
30 Jun 21 | 34 | -9 | 1 | 0 |
31 Mar 21 | 32 | -10 | 1 | 0 |
31 Dec 20 | 30 | -13 | 1 | 0 |
30 Sep 20 | 23 | -24 | 1 | 0 |
30 Jun 20 | 29 | -20 | 1 | 0 |
31 Mar 20 | 32 | -19 | 1 | 0 |
31 Dec 19 | 38 | -13 | 1 | 0 |
31 Dec 18 | 42 | -28 | 2 | 0 |
31 Dec 17 | 11 | -34 | 3 | 0 |
Guadagni di qualità: ELABSO is currently unprofitable.
Margine di profitto in crescita: ELABSO is currently unprofitable.
Flusso di cassa libero e analisi degli utili
Analisi della crescita degli utili nel passato
Andamento degli utili: ELABSO is unprofitable, and losses have increased over the past 5 years at a rate of 2.7% per year.
Accelerare la crescita: Unable to compare ELABSO's earnings growth over the past year to its 5-year average as it is currently unprofitable
Guadagni vs Settore: ELABSO is unprofitable, making it difficult to compare its past year earnings growth to the Software industry (13.7%).
Rendimento del capitale proprio
ROE elevato: ELABSO has a negative Return on Equity (-10.7%), as it is currently unprofitable.